Saxagliptin hydrochloride
- Level
- Commodity
- Parent
- 51183300
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51183307This classification denotes a protease inhibitor and anti-diabetic agent with the molecular formula C18H25N3O2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8J84YIX6L. European Medicines Agency schedules saxagliptin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30804. The term saxagliptin hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule saxagliptin hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, SAXAGLIPTIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Saxagliptin hydrochloride bears US NLM identifiers UMLS ID C2719771 and NCI Concept Code C81702. SMILES: C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H]([C@]34C[C@@H]5CC(C3)C[C@@](C5)(C4)O)N.CL.
Same parent
Under 51183300 · 9Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.